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Abstract. 
 
About 50% of spinal motoneurons undergo 
programmed cell death (PCD) after target contact, but 
little is known about how this process is initiated. Em-
bryonic motoneurons coexpress the death receptor Fas 
and its ligand FasL at the stage at which PCD is about 
to begin. In the absence of trophic factors, many moto-
neurons die in culture within 2 d. Most (75%) of these 
were saved by Fas-Fc receptor body, which blocks inter-
actions between Fas and FasL, or by the caspase-8 in-
hibitor tetrapeptide IETD. Therefore, activation of Fas 
by endogenous FasL underlies cell death induced by 
trophic deprivation. In the presence of neurotrophic 
factors, exogenous Fas activators such as soluble FasL 
or anti-Fas antibodies triggered PCD of 40–50% of pu-
riﬁed motoneurons over the following 3–5 d; this treat-
ment led to activation of caspase-3, and was blocked by 
IETD. Sensitivity to Fas activation is regulated: moto-
neurons cultured for 3 d with neurotrophic factors be-
came completely resistant. Levels of 
 
Fas
 
 expressed by 
motoneurons varied little, but 
 
FasL
 
 was upregulated in 
the absence of neurotrophic factors. Motoneurons
resistant to Fas activation expressed high levels of 
FLICE-inhibitory protein (FLIP), an endogenous in-
hibitor of caspase-8 activation. Our results suggest that 
Fas can act as a driving force for motoneuron PCD, and 
raise the possibility that active triggering of PCD may 
contribute to motoneuron loss during normal develop-
ment and/or in pathological situations.
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HE
 
 existence of a phase of programmed cell death
(PCD)
 
1
 
 in the normal development of spinal moto-
neurons has been known for many decades, since
the pioneering work of Hamburger and Levi-Montalcini
(for review see Hamburger, 1992). A considerable body of
work has since been devoted to the study of this phenome-
non, making the motoneuron a locus classicus of cell death
research in the nervous system (for reviews see Oppen-
heim, 1991; Pettmann and Henderson, 1998). During the
4–6 d after target muscle contact, an average of 50% of the
motoneurons initially generated undergo PCD at most
levels of the spinal cord. This death has many features that
classify it as apoptotic: (a) characteristic morphological
changes such as shrinkage and condensation have been re-
ported (Chu-Wang and Oppenheim, 1978a,b); (b) admin-
istration of caspase inhibitors to chicken embryos protects
many motoneurons against PCD in ovo (Milligan et al.,
1995; Li et al., 1998); and (c) motoneuron death is almost
completely abrogated in mouse embryos deficient for Bax,
a proapoptotic member of the Bcl-2 family (Deckwerth et al.,
1996; White et al., 1998).
The fraction of motoneurons that survive the phase of
PCD is tightly linked to the presence of the target tissue:
early removal of a limb bud leads to death of nearly all
motoneurons that would normally have innervated it
(Hamburger, 1934). Thus, limb tissues normally produce
neurotrophic factors and when these are absent, motoneu-
rons activate a cell death process. What drives the death
of motoneurons (or indeed other neurons) deprived of
trophic support is not clear. It is possible that in the ab-
sence of signaling through survival-related cascades, cas-
pase activation occurs spontaneously. However, specific
molecular events may also serve as a driving force for
death induced by trophic deprivation.
The fact that the 50% of motoneurons that normally
survive require trophic support led to the hypothesis that
the other 50% die through lack of sufficient support. In-
deed, there is support for this idea, since grafting a super-
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numerary limb bud can save some of the motoneurons
that normally die (Hollyday and Hamburger, 1976). Simi-
lar effects are observed when neurotrophic factors or tis-
sue extracts are exogenously administered to chicken em-
bryos in ovo (Oppenheim et al., 1991, 1995). Nevertheless,
it is striking that it has not been possible to save all moto-
neurons in this manner, and that to date, transgenic over-
expression of neurotrophic factors in muscle has not been
reported to save motoneurons (Nguyen et al., 1998). Fur-
thermore, many agents capable of reducing naturally oc-
curring motoneuron death in chicken embryos are not ef-
fective in saving motoneurons that have been deprived of
trophic support by limb ablation (Calderò et al., 1998).
Thus, it is possible that at least a proportion of naturally
occurring motoneuron PCD may be triggered by mecha-
nisms other than trophic deprivation.
Different mechanisms for controlled elimination of neu-
rons during development are indeed known to exist. In
nematodes, genes such as 
 
ces-2
 
 seem to act cell-autono-
mously to trigger PCD (Ellis and Horvitz, 1991; Metzstein
et al., 1996). Another possibility in vertebrates is that ex-
ogenous influences may trigger the death of specific popu-
lations. Although this type of mechanism has been widely
analyzed in lesioned adult brain (e.g., excitotoxicity), it
had not been intensely studied during development until
recently. However, a series of recent results on PCD trig-
gered by NGF signaling through the low-affinity neurotro-
phin receptor p75
 
NTR
 
 have radically changed our vision of
this question (for review see Carter and Lewin, 1997). In
the developing retina for instance, the early role of NGF
seems not to be as a trophic factor, but rather as a trigger
of PCD: in the absence of NGF or p75 function, cell death
among the population of immature retinal neurons that
express p75 is markedly reduced (Frade and Barde, 1999).
The source of NGF appears to be macrophages that in-
vade the developing retina at early stages (Frade and
Barde, 1998). Therefore, the PCD of at least some neu-
ronal populations seems to be regulated by molecules that
actively trigger cell death.
p75
 
NTR
 
 is a member of the tumor necrosis factor (TNF)
receptor family of transmembrane receptors, many of
which carry in their cytoplasmic domain a group of about
80 amino acids referred to as the death domain, which al-
lows them to interact with adaptor molecules and thereby
indirectly mediate caspase activation in the cell (Ash-
kenazi and Dixit, 1998). Another well-studied member of
this family is the Fas/Apo1/CD95 receptor (referred to
here as Fas), which with its ligand FasL has well-studied
roles in instructive apoptosis (for review see Nagata,
1997). In the immune system, Fas and FasL are involved in
deletion of mature T cells to end an immune response, in
triggering death of inflammatory cells, and in elimination
of infected cells or tumors by cytotoxic T lymphocytes
(Nagata and Golstein, 1995). FasL, which can act either in
membrane-bound or soluble form, triggers cell death by
clustering the Fas receptor at the cell surface. In these con-
ditions, the cytoplasmic domain of Fas can bind the adap-
tor protein Fas-associated death domain (FADD)/Mort1
(Chinnaiyan et al., 1995). FADD in turn binds procas-
pase-8, which can thereby self-activate (Muzio et al.,
1996). Cleavage of downstream substrates by caspase-8
rapidly triggers the cell death cascade in the cell that ex-
 
pressed Fas (Scaffidi et al., 1998). FasL can activate Fas
both in 
 
trans
 
 and in 
 
cis
 
: T lymphocytes induced to die by
T cell receptor ligation upregulate FasL and Fas at their
surface and thus trigger cell death in an autocrine man-
ner (Brunner et al., 1995; Dhein et al., 1995). Partial loss-
of-function mutations for Fas (
 
lpr
 
) and FasL (
 
gld
 
) in
mouse lead to accumulation of peripheral lymphoid cells
and to an autoimmune disorder (Watanabe-Fukunaga et
al., 1992; Takahashi et al., 1994).
The potential role of Fas in the nervous system has been
the object of relatively little study. It is known that FasL is
quite widely expressed in the nervous system (Becher et al.,
1998a), but its presence has been related to a role in con-
ferring immune privilege on the central nervous system
through its ability to trigger death of invading lymphocytes
(French et al., 1996; French and Tschopp, 1996; Saas et al.,
1997). However, there have been reports of expression of
Fas itself in the nervous system. After spinal cord ischemia
in adult rabbits, increases in Fas immunoreactivity of spi-
nal motoneurons precede cell death (Sakurai et al., 1998).
Furthermore, specific neuronal populations in postnatal
mouse brain were shown to express Fas mRNA and pro-
tein even in nonlesioned animals (Park et al., 1998). Very
recently, the Fas–FasL system has been implicated in cell
death induced by ischemia (Martin-Villalba et al., 1999),
as well as in death of PC12 cells and cerebellar granule
neurons (Le-Niculescu et al., 1999) and cortical neurons
(Cheema et al., 1999) in vitro.
We wished to investigate the possibility that some moto-
neuron cell death may be actively triggered. We show here
that both Fas and FasL are expressed by motoneurons at
the time at which PCD is about to begin in the spinal cord.
In vitro, interaction of endogenous FasL with Fas drives
death induced by trophic deprivation, and exogenous acti-
vation of Fas triggers PCD of motoneurons even in the
presence of neurotrophic factors. The extent and timing of
the Fas-induced cell death are close to those observed in
vivo, and neurotrophic factors regulate synthesis of both
death-inducing and death-inhibitory factors. Our results
are consistent with the possibility that motoneuron cell
death in vivo may be actively triggered via Fas.
 
Materials and Methods
 
Reagents and Animals
 
Recombinant human APO-1/Fas–Fc IgG (Fas-Fc), soluble Fas-ligand
(sFasL), and enhancer antibodies used for aggregating tagged sFasL were
from Alexis Corp. Rabbit polyclonal antibodies against Fas (M-20) and
against FasL (N-20) and the related control peptides were from Santa
Cruz Biotechnology, Inc. Polyclonal rabbit antibodies to mouse FLICE-
inhibitory protein (FLIP) were from R & D Systems, Inc., and mouse
mAbs to neurofilament 68-kD subunit (NF-68) were from Sigma Chemi-
cal Co. mAb against FasL (H11) was purchased from Alexis Corp. Rat
anti–mouse Fas mAbs (RMF6) were from Chemicon International, Inc.
Control rat IgG 2a were obtained from PharMingen International and
control rabbit Ig from Jackson ImmunoResearch Laboratories, Inc.
DEVD-fmk (Asp-Glu-Val-Asp-fluoro methyl ketone) was purchased
from Enzyme Systems Products and IETD-fmk (Ile-Glu-Thr-Asp-fluoro
methyl ketone) from Clontech Laboratories, Inc. All mutant mice and
control strains were purchased from Jackson Laboratories, Inc.
 
RNA Detection by Reverse Transcription PCR
 
Total RNA was isolated from different tissues and cells using the guani-
dine isothiocyanate-phenol chloroform method (Chomczynski and Sacchi, 
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1987). Reverse transcription (RT) steps were performed using Expand™
reverse transcriptase (Roche Diagnostics) and random hexamer primers.
Normalization of cDNA amounts was performed by PCR on a Perkin-
Elmer Thermal Cycler, using primers for 
 
b
 
-actin
 
 (sense primer TT GTA
ACC AAC TGG GAC GAT ATG G and antisense primer GAT CTT
GAT CTT CAT GGT GCT AGG). PCR reactions were performed for a
total of 24 cycles.
 
Fas
 
 and 
 
FasL
 
 cDNA were amplified using primers for rat 
 
Fas
 
 (nucle-
otides 147–168, CTG TCC TGC CTC TGG TGC TTG, and nucleotides
682–702, CAT CTG AGA CAT TCA TTG GC; sequence data available
from EMBL/GenBank/DDBJ under accession no. D26112) and rat 
 
FasL
 
(nucleotides 30–51, CCA CAA GAC TGA GAG GAG GAA A, and
nucleotides 814–836, TAA ATG GTC AGC AAC GGT AAG A; se-
quence data available from EMBL/GenBank/DDBJ under accession no.
U03470). The reaction mixture contained 20 mM Tris-HCl, pH 8.4, 50 mM
KCl, 0.2 mM each dNTP, 1.5 mM MgCl
 
2
 
, 1.5 U of 
 
Taq
 
 platinum poly-
merase (Roche Diagnostics), 20 pmol of each primer and a normalized
amount of cDNA template. The PCR conditions for both sets of primers
were 30 s at 94
 
8
 
C, 30 s at 60
 
8
 
C, 1 min at 72
 
8
 
C for a total of 35 cycles.
Samples were then run on a 1.2% agarose gel, treated with 0.4 N NaOH
and transferred to Hybond N
 
1
 
 nylon membranes (Amersham Pharmacia
Biotech). Blots were hybridized with 
 
32
 
P-labeled probes corresponding to
nucleotides 174–196, CCG ACA ACA ACT GCT CAG AAG G for rat
 
Fas
 
,
 
 
 
and nucleotides 347–368, ACA TTC CTA ACC CCA TTC CAA C
for 
 
FasL
 
,
 
 
 
at 42
 
8
 
C for 2 h. Membranes were then washed in decreasing con-
centrations of saline sodium citrate buffer (SSC), and exposed for autora-
diography.
For RT-PCR from cultures, a total of 50,000 motoneurons were seeded
in five 35-mm dishes for each culture condition and rinsed with diethyl py-
rocarbonate (DEPC)-treated PBS. Total RNA was isolated using TRIzol
(Life Technologies, Inc.) reagent, and cDNA normalization was per-
formed as above. Primers used were as follows: mouse 
 
Fas
 
, nucleotides
273–292, CAC CAA CCT GTG CCC CAT GC, and nucleotides 999–
1019, GTC CTT CAT TTT CAT TTC CAG (sequence data available
from EMBL/GenBank/DDBJ under accession no. M83649); mouse
 
FLIP
 
, nucleotides 226–247, TGA TGA AGA CGA GAA GGA GAT,
and nucleotides 795–815, AAT CTT GGC TCT TTA CTT CGC (se-
quence data available from EMBL/GenBank/DDBJ under accession no.
U97076). The PCR conditions were 30 s at 94
 
8
 
C, 30 s at 58
 
8
 
C for 
 
Fas
 
 or
54
 
8
 
C for 
 
FLIP
 
, and 45 s at 72
 
8
 
C for a total of 35 cycles, using the same re-
action conditions as described above. PCR products were separated on a
1.2% agarose gel and visualized by ethidium bromide staining. The rela-
tive intensity of ethidium bromide–stained bands was determined using an
AGFA densitometer, and data were analyzed using the NIH Image 1.62
software.
 
Immunoblot Purification of Antibodies to Fas
 
Rabbit polyclonal antibodies against Fas antigen (M-20) were immuno-
blot-purified using a procedure described previously (La Bella et al., 1998).
In brief, 5 mg of mouse thymus protein extract was submitted to prepara-
tive PAGE electrophoresis and Western blotting. The horizontal strip
corresponding to Fas (45 kD) was cut out of the blot and incubated with 1
 
m
 
g/ml M-20, then washed. Subsequently, bound antibody was eluted using
a glycine buffer, pH 2.8, and rapidly buffered to pH 7.5. This step greatly
decreased nonspecific staining observed using the initial preparation (data
not shown). An identical immunopurification was performed using blots
of E12.5 mouse ventral spinal cord extracts (see text).
 
Western Blotting
 
Tissues were collected in cold PBS, centrifuged to remove excess PBS and
placed in lysis buffer (50 mM Tris-HCl, 1 mM EDTA, 100 mM DTT, 1 mM
PMSF, 2% SDS, 500 mM NaCl and Complete™ EDTA-free, a protease
inhibitor mix purchased from Roche Diagnostics). After mechanical dis-
sociation followed by sonication, lysates were centrifuged (12,000 rpm for
5 min) and the supernatant was heated at 95
 
8
 
C for 2 min in loading buffer
(10% [vol/vol] glycerol, 2% [wt/vol] 2-mercaptoethanol, 250 mM Tris, pH
6.8, 0.005% bromophenol blue). Loading was 20 
 
m
 
g of proteins for adult
tissue extracts and 40 
 
m
 
g for all embryonic tissues and cells, as determined
using a modified Bradford reaction (Bio-Rad Laboratories). Proteins
were separated by SDS-PAGE (12% acrylamide gel) and transferred to
Immobilon membranes (Millipore). Membranes were blocked with 10%
nonfat dry milk in PBS 0.1% Tween 20 (PBT) for 2 h at room tempera-
ture, then incubated with primary antibodies diluted in PBT containing
4% milk (100 ng/ml for FasL N-20 and Fas M-20 antibodies, 450 ng/ml for
caspase-8 antibodies, 1 
 
m
 
g/ml for c-FLIP antibodies, and 50 ng/ml for NF-
68 antibodies) overnight at 4
 
8
 
C. After washing with PBT, membranes
were incubated with HRP-conjugated secondary antibodies (Jackson Im-
munoResearch Laboratories, Inc.) diluted in PBT containing 4% milk, for
1 h, washed with PBT and then developed using the ECL system (Amer-
sham Pharmacia Biotech). Scanning was performed as for RT-PCR.
 
Motoneuron Purification and Culture
 
E14 rat and E12.5 mouse spinal motoneurons were purified as described
previously (Henderson et al., 1995; Arce et al., 1999). In brief, cells were
dissociated from ventral spinal cord after trypsin treatment. The largest
cells were isolated by centrifugation on a 6.5% metrizamide density gradi-
ent. The immunoaffinity purification step performed previously by immu-
nopanning (Henderson et al., 1995) was replaced by a cell-sorting step
using magnetic microbeads (Arce et al., 1999). For rat, cells in the metriza-
mide fraction were incubated with a mouse mAb against rat p75
 
NTR
 
(Ig192); for mouse, with a rat mAb against mouse p75
 
NTR
 
 (Chemicon).
Subsequently, motoneurons were incubated with magnetic microbeads
conjugated to either mouse anti–rat or rat anti–mouse secondary antibod-
ies, thus allowing the purification of motoneurons on separating columns
(Miltenyi Biotec, Inc.). After a final centrifugation through a BSA cush-
ion, motoneurons were resuspended in either L15 or neurobasal medium
and plated in 4-well dishes (Nunc) previously treated with polyornithine/
laminin as described (Henderson et al. 1995).
Neurobasal medium (Life Technologies, Inc.) was supplemented with
2% (vol/vol) horse serum, 25 
 
m
 
M 
 
L
 
-glutamate, 25 
 
m
 
M 
 
b
 
-mercaptoethanol,
0.5 mM 
 
L
 
-glutamine, and 2% (vol/vol) B-27 supplement (Life Technolo-
gies, Inc.). L15 (Leibovitz) medium (Life Technologies, Inc.) was sup-
plemented with 2% (vol/vol) horse serum, 3.6 mg/ml glucose, 100 U/ml
penicillin-streptomycin, 20 nM progesterone, 5 
 
m
 
g/ml insulin, 0.1 mM pu-
trescine, 0.1 mg/ml conalbumin, 30 nM sodium selenite.
For rat motoneurons, the different neurotrophic factors were used at
the optimal concentrations as follows: human brain-derived neurotrophic
factor (BDNF) (R & D Systems, Inc.) at 1 ng/ml, rat glial cell line–derived
neurotrophic factor (GDNF) (Sigma Chemical Co.) at 100 pg/ml, mouse
cardiotrophin-1 (CT-1) (Genentech, Inc.) at 10 ng/ml. Mouse motoneu-
rons were cultured in the presence of a cocktail of trophic factors (NTFs)
consisting of ciliary neurotrophic factor (CNTF; 10 ng/ml). All factors
were added at the time of cell seeding.
 
Assay of Motoneuron Survival
 
Rat or mouse motoneurons were seeded in 4-well plates and cultured in
the indicated medium at the density of 1,000–2,000 cells per 16-mm well.
Motoneurons were grown for 24 h at 37
 
8
 
C before being incubated with
Fas activators at the indicated concentrations diluted in neurobasal me-
dium. Treatments with sFasL were always performed in the presence of 1
 
m
 
g/ml enhancer antibody. The activity of the different death-inducing
agents was determined after different periods of treatment by direct
counting of living cells using a phase-contrast microscope. Fas-Fc or
IETD-fmk were added at the time of seeding, and the surviving motoneu-
rons were counted after 24 h at 37
 
8
 
C in the indicated culture medium.
Counts were performed using a phase-contrast microscope: 
 
z
 
100 moto-
neurons in 2 diameters of each well were evaluated as described previ-
ously (Henderson et al., 1994; Pennica et al., 1996). All assays were per-
formed in duplicate or triplicate wells in each of two to four independent
experiments.
 
Immunohistochemistry
 
Approximately 3,000 purified motoneurons were seeded per polyorni-
thine/laminin–coated 12-mm diameter glass coverslip, and grown for 1 or
3 d at 37
 
8
 
C in neurobasal medium with trophic factors. Cultures were
fixed on ice using freshly made paraformaldehyde, first for 10 min with
2% paraformaldehyde in PBS-neurobasal medium (1:1), then for 10 min
with 4% paraformaldehyde in PBS. Cultures were washed three times
with PBS, permeabilized with 50 mM 
 
L
 
-Lysine, 0.1% Triton X-100 in PBS
for 10 min, and incubated overnight at 4
 
8
 
C in PBS containing 4% BSA,
2% goat or donkey serum (species depending on the secondary antibod-
ies). The primary antibodies were diluted in PBS containing 4% BSA, 2%
donkey and goat serum at the following concentrations: 0.2 
 
m
 
g/ml for rab-
bit polyclonal antibodies against FasL (N-20) and Fas (M-20), 20 
 
m
 
g/ml
for anti-Fas (RMF-6), 0.9 
 
m
 
g/ml for caspase-8 rabbit polyclonal antibod-
ies, and matching concentrations for each control antibody. Cells were in- 
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cubated with primary antibodies overnight at 4
 
8
 
C, then washed with PBS
containing 0.1% Triton and incubated for 30–45 min at room temperature
with fluorophore-conjugated anti–rabbit, anti–mouse, or anti–rat second-
ary antibodies (Jackson ImmunoResearch, Inc.) diluted in PBS 10% horse
serum. After washing with PBS containing 10% horse serum and PBS,
cultures were rinsed with double-distilled water before being mounted on
glass slides using DABCO mounting solution and examined by fluores-
cence microscopy. Immunostaining using the polyclonal antibody CM1 to
detect the activated form of caspase-3 was performed as described (Srini-
vasan, 1998b). To label all nuclei, immunostained preparations were incu-
bated with a solution of 4
 
9
 
,6-diamidino-2-phenylindole dihydrochloride
(DAPI) at 200 ng/ml in PBS for 15 min in the dark before washing and
mounting.
 
Results
 
Fas and FasL Are Expressed by Embryonic 
Motoneurons as PCD Begins
 
We first asked whether Fas and FasL are expressed at the
stage at which motoneuron PCD is about to begin. By RT-
PCR followed by Southern blotting using specific oligonu-
cleotide probes, we showed that, as reported (Suda et al.,
1993; French et al., 1996), 
 
Fas
 
 and 
 
FasL
 
 were both ex-
pressed in a variety of adult tissues (Fig. 1, A and B; data
not shown), and that 
 
FasL
 
 was expressed by ventral spinal
cord of E14 rat embryos (Fig. 1 A). In addition, we
showed that 
 
Fas
 
 was expressed at significant levels by
freshly isolated E14 ventral spinal cord (Fig. 1 B).
Because levels of mRNA were not high enough to be
reproducibly detected by in situ hybridization (data
not shown), we used an alternative approach. To deter-
mine whether motoneurons themselves expressed 
 
Fas
 
 and
 
FasL
 
, we purified E14 rat motoneurons to near-homoge-
neity using the metrizamide-immunoaffinity method (see
Materials and Methods). All purification steps were per-
formed below 20
 
8
 
C to reduce de novo synthesis. mRNAs
for both Fas and FasL were clearly present in freshly iso-
lated motoneurons (Fig. 1, A and B), demonstrating that
motoneurons about to undergo PCD in vivo potentially
express the elements of the Fas–FasL system.
 
Embryonic Motoneurons Coexpress Fas and
FasL Polypeptides
 
Next, we determined whether motoneurons express signif-
icant levels of Fas and FasL protein. By Western blotting
using a polyclonal antibody to FasL, we detected a band of
the appropriate molecular mass (38 kD) in adult thymus
but not in heart, as expected from previous reports (Suda
et al., 1993) and our RNA data (Fig. 1 A). The same anti-
body clearly detected FasL in ventral spinal cord from
both E14 rat and E12.5 mouse embryos and in purified rat
motoneurons of the same age (Fig. 2 A).
Several commercial antibodies to Fas we tested reacted
with multiple bands on Western blots (data not shown).
Therefore, we affinity-purified anti-Fas antibodies from
polyclonal rabbit Ig (M-20) raised against the intracellular
domain of Fas (see Materials and Methods). On Western
blots of thymus from P17 mice, this antibody recognized a
band that migrated with an apparent molecular mass of 45
kD, the expected molecular mass for Fas (Fig. 2 B). The
intensity of this band was greatly reduced in thymus from
P17 
 
lpr/lpr
 
 mice (Fig. 2 B), in which levels of Fas have
been reported to be at least 10-fold lower than normal
(Mariani et al., 1994). Also as expected (French et al.,
1996), Fas protein was detected in adult heart, but not eye
(Fig. 2 C). In the same conditions, the immunopurified an-
tibody recognized a band of identical molecular mass in
extracts of ventral spinal cord from E14 rat and E12.5
mouse, and in motoneurons freshly purified from E14 rat
spinal cord (Fig. 2 C). When the antibody was preincu-
bated with the immunogenic peptide, no staining was seen
(data not shown). As a final demonstration that the
polypeptide present in spinal cord and motoneurons was
indeed Fas, we immunopurified the Fas antibodies by in-
cubation with the 45-kD band cut out from Western blots
of E12.5 mouse spinal cord. The eluted antibodies recog-
nized a 45-kD band in thymus that disappeared in 
 
lpr/lpr
 
tissue (data not shown). Thus, Fas protein is expressed at
significant levels by spinal motoneurons (and perhaps
other spinal neurons) at the onset of motoneuron PCD.
However, we were not able to immunolocalize Fas reliably
on embryonic tissue sections (data not shown).
Figure 1. Embryonic motoneurons express Fas and FasL both in
situ and after purification. Total RNA was prepared from the in-
dicated rat tissues, and RT-PCR analysis followed by Southern
blotting was performed using specific primers and internal
probes for FasL (A) and Fas (B). RT-PCR for b-actin was used
as an internal control to ensure that similar concentrations of
mRNA were present in all samples. For each mRNA, the first
panel corresponds to positive and negative control samples pre-
pared from indicated tissues of adult rat; the results are in agree-
ment with several reports in the literature. The second panel
shows results from E14 rat embryos, using either freshly dis-
sected ventral spinal cord or motoneurons purified by a metriza-
mide-immunoaffinity method in conditions that limit de novo
synthesis of mRNA. Fas and FasL are present at significant levels
in motoneurons. Alternate unlabeled lanes in all panels are con-
trol in which reverse transcriptase was omitted from the incuba-
tion. 
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We performed immunolabeling studies on purified
mouse (Fig. 3) and rat (data not shown) motoneurons cul-
tured for 1 d with neurotrophic factors. For Fas, using the
affinity-purified Ig described above, granular membrane
labeling was observed in nearly all cultured motoneurons,
although some were more intensely labeled than others
(Fig. 3 A). Similar results (data not shown) were obtained
using rat mAb RMF6 raised against the extracellular do-
main of Fas. The rabbit antibodies also reproducibly
stained the nuclei of cultured motoneurons; both this and
the membrane immunoreactivity were absent when the
antibody was preincubated with the peptide used for im-
munization (Fig. 3 B). Antibodies to FasL also stained
nearly all motoneurons (Fig. 3 C), and double-labeling ex-
periments confirmed that most individual neurons coex-
pressed Fas and FasL (Fig. 3 D).
 
Motoneuron Death Induced by Trophic Deprivation 
Involves Endogenous Activation of Fas and Caspase-8
 
Since motoneurons coexpressed the death receptor Fas to-
gether with its ligand, we asked whether Fas might play a
role in motoneuron cell death. When purified rat moto-
neurons were grown in basal medium at low density (1,000
per 16-mm well) for 24 h, about half of them died (Fig. 4
A). Their death was completely prevented by BDNF (1
ng/ml). Fas-Fc, which contains the extracellular domain of
Fas fused to an Ig Fc domain, is an antagonist known to
block activation of Fas by FasL. Fas-Fc inhibited 
 
z
 
75% of
the  death of trophically deprived motoneurons in a
dose-dependent manner (Fig. 4 A). Higher doses of Fas-
Fc were slightly less efficient (data not shown), but this
may have been due to toxicity of the reagent. This sug-
gested that endogenous FasL was activating Fas in these
neurons, thereby triggering the cell death process.
Fas-triggered cell death in nonneuronal systems in-
volves activation of caspase-8, which then activates down-
stream caspases such as caspase-3 (Nicholson and Thorn-
berry, 1997). Using a specific antibody to caspase-8 that
recognizes both the inactive procaspase and the active
forms (Srinivasan et al., 1998a), we found that nearly all
cultured motoneurons showed a characteristic pattern of
cytoplasmic labeling (Fig. 4 B). We then tested the hy-
pothesis that caspase-8 might be an essential relay in the
death of motoneurons induced by trophic deprivation.
Prior application of the caspase-8–selective inhibitor pep-
tide IETD-fmk (Garcia-Calvo et al., 1998), which alone
did not affect survival in BDNF, inhibited 75% of the mo-
toneuron loss observed in the absence of trophic support
(Fig. 4 C), consistent with a requirement for caspase-8 in
this process.
To determine whether caspase-8 is present in motoneu-
rons in vivo, we performed Western blots on different tis-
sue extracts (Fig. 4 D). As expected, nonapoptotic HeLa
and Jurkat cells showed a principal doublet around 53–55
kD, which corresponds to the forms referred to as caspase-
8/a and caspase-8/b (Scaffidi et al., 1997). Spinal cord ex-
tracts and freshly purified motoneurons showed a single
major caspase-8–immunoreactive band at 43 kD (Fig. 4
D). It is not possible to determine from these data whether
this form is identical to p43, a known intermediate in the
caspase-8 activation process in nonneuronal cell types
(Scaffidi et al., 1997), and it is possible that it results from
other posttranslational modifications than those observed
in cell lines. However, we do not believe that the 43-kD
form in nervous tissue is proteolytically active, since we
detected it at similar levels in normal adult spinal cord,
where little or no PCD occurs (data not shown). Thus,
caspase-8, a central component of the Fas signaling path-
way, is present in normal spinal cord during the period of
naturally occurring motoneuron death.
 
Fas Can Trigger Motoneuron Cell Death in a Manner 
Independent of Trophic Deprivation
 
In view of the finding that blockade of the Fas system
saves motoneurons deprived of trophic support (Fig. 4),
Figure 2. Embryonic motoneurons express Fas and FasL
polypeptides in vivo. Western blot analysis was performed using
specific antibodies to FasL and Fas. (A) Antibodies to FasL spe-
cifically label a 38-kD band in P17 mouse thymus, but not in
heart. In ventral spinal cord from rodent embryos dissected at the
stage at which motoneuron PCD is about to begin, FasL is abun-
dant. It is also clearly present in freshly purified motoneurons
from E14 rat. (B) Controls for the specificity of immunoblot-
purified anti-Fas antibodies (M-20) using thymus extracts from
P17 mice of the C57BL/6 strain. Wild-type (1/1) and Fas mutant
(lpr/lpr) samples are shown. (C) Using immunoblot-purified anti-
bodies, Fas is abundant in adult rat heart but not in eye. Both
ventral spinal cord and freshly purified motoneurons from embryos
show clear expression of a single band corresponding to Fas. 
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we next asked whether Fas activation could trigger moto-
neuron death even in the presence of trophic factors. To
do this, we took advantage of reagents that have been
shown to cluster Fas at the cell membrane in other systems
and thereby exogenously trigger Fas-dependent cell death.
Motoneurons purified from E12.5 mouse embryos were
cultured in the presence of a cocktail of trophic factors
(BDNF, CNTF, and GDNF) at concentrations determined
previously to ensure optimal survival (Arce et al., 1999).
After 24 h to allow attachment and initial neurite out-
growth, antibody to the extracellular domain of mouse Fas
was added in the continued presence of trophic factors to
induce clustering of Fas. 2 d later (i.e., after 3 d in vitro
[DIV]), anti-Fas antibody had caused dose-dependent mo-
toneuron loss, up to a maximum reduction of 45% using 10
ng/ml antibody (Fig. 5 A). The half-maximal dose of anti-
body required to induce death of motoneurons (0.7 ng/ml)
is close to that reported for lymphoid cells (Watanabe-
Fukunaga et al., 1992). Control antibodies including the
enhancer antibody (see below) had no effect on survival
(data not shown).
To confirm the generality of this observation, we per-
formed an analogous experiment on cultured rat moto-
neurons. Since rat Fas is not recognized by the clustering
antibody, we used a recombinant form of the extracellular
domain of FasL (sFasL) that is epitope-tagged. Addition
of sFasL, followed by an antibody to this tag (enhancer an-
tibody), clusters sFasL and thereby Fas, leading to Fas ac-
tivation. Rat motoneurons were cultured for 1 d in the
presence of optimal concentrations of BDNF (1 ng/ml).
They were then treated with enhancer, either alone or in
the presence of increasing concentrations of sFasL. En-
hancer antibody alone (1 
 
m
 
g/ml) did not affect survival,
but in the presence of sFasL, 40% of motoneurons were
Figure 3. Motoneurons in culture coexpress Fas and FasL. Immunolabeling of purified E12.5 mouse motoneurons cultured for 1 d in
the presence of neurotrophic factors. (A) Cultured motoneurons labeled using blot-purified rabbit anti-Fas (M-20). Note punctate la-
beling of cell membranes and more diffuse labeling of nucleus. There was variation in intensity from cell to cell (not apparent in this
field). (B) Control in which the same primary antibody was preincubated with the immunogenic peptide. Preincubation with an irrele-
vant peptide did not reduce staining (data not shown). (C) Immunostaining using a rat mAb against FasL (H11). Note the strong homo-
geneous staining. (D) Double immunolabeling for Fas (green) and FasL (red), showing the death receptor and its ligand present at the
cell surface of the same motoneuron. Controls using an irrelevant rat mAb of the same class or purified rabbit antibodies gave no signif-
icant staining (data not shown). 
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lost 2 d later in a dose-dependent fashion, with an EC
 
50
 
 of
1 ng/ml (Fig. 5 B). This is close to the half-maximal dose
necessary to trigger death of A20 B lymphoma cells
(Hahne et al., 1996). Strikingly, in this model too, moto-
neuron death was not enhanced by further increasing the
concentrations of sFasL.
We compared the percentage of motoneurons induced
to die by Fas activation in the presence of different factors.
Rat motoneurons were cultured as described above, ex-
cept that BDNF (1 ng/ml) was replaced by CT-1 (10 ng/ml),
or GDNF (0.1 ng/ml), or CNTF (10 ng/ml; data not
shown). The reduction in motoneuron number after 2 d
was expressed as a percentage of the number surviving in
the same conditions without sFasL (Fig. 5 C). In each case,
sFasL triggered death of 
 
z
 
30% of motoneurons, and simi-
lar results were obtained using FasL in basal medium
alone (data not shown).
 
Role of Caspases-3 and -8 in Cell Death Induced by 
Exogenous Fas Activators
 
To demonstrate that the motoneurons lost after Fas acti-
vation had activated a cell death program, we studied the
involvement of caspases.
We first focused on caspase-3, a downstream caspase
known to be required for PCD of many neurons (Kuida
et al., 1996), and of motoneurons in particular (Li et al.,
1998). Using an antibody (CM1) that specifically recog-
nizes the activated form of caspase-3 (Srinivasan et al.,
1998b), we showed that many cultured motoneurons ex-
posed to Fas activators expressed activated caspase-3, and
that this reactivity was especially strong in the motoneu-
rons with apoptotic nuclei that had not yet detached from
the culture dish (Fig. 6 A). We quantified CM1-positive
motoneurons 30 h after treatment (or not) with anti-Fas
antibodies (Fig. 6 B). At this stage, there was not yet a sig-
nificant difference in total motoneuron numbers in the
presence or absence of anti-Fas (
 
P
 
 . 
 
0.5; data not shown).
Without Fas activator, 8.0 
 
6 
 
0.9% (mean 
 
6 
 
SEM;
 
 n 
 
5 
 
5)
of motoneurons expressed intense CM1 immunoreactivity
and showed fragmented chromatin using Hoechst staining.
Using anti-Fas antibodies, this value was significantly in-
creased (19.0 
 
6 
 
1.6%;
 
 P 
 
5 
 
0.001 by 
 
t
 
 test). To test the
functional significance of caspase-3 activation, we used
the active-site peptide DEVD, a potent cell-permeable
caspase inhibitor that is selective for caspase-3 (Nicholson
et al., 1995; Villa et al., 1997), but can also inhibit caspase-8
(Garcia-Calvo et al., 1998). Increasing concentrations of
DEVD-fmk were added to rat motoneurons cultured in
BDNF, 2 h before addition of sFasL (10 ng/ml) and en-
hancer antibody. Motoneuron loss was inhibited in a dose-
dependent fashion (Fig. 6 C), and the concentration of
DEVD required to completely prevent Fas-dependent
motoneuron death (10 
 
m
 
M) was similar to or lower than
those reported to prevent PCD in other cell types (Arm-
strong et al., 1997). DEVD was also able to completely in-
hibit the cell death of mouse motoneurons induced by
sFasL or anti-Fas antibodies (Fig. 6 D). Thus, Fas most
likely triggers PCD of motoneurons by a mechanism in-
volving caspase-3.
In similar experiments, the caspase-8 inhibitor IETD-
fmk was able to completely prevent the motoneuron loss
induced by sFasL (Fig. 6 E), consistent with a requirement
for caspase-8 in this process.
 
Resistance to Fas-induced Cell Death Is Regulated
In Vitro
 
It was striking (Fig. 5) that 
 
z
 
50% of motoneurons were
resistant to the effects of exogenous Fas activation in the
presence of trophic factors. We tested the survival of
mouse motoneurons treated at different stages with Fas
activators (Fig. 7). In a first experiment analogous to those
Figure 4. Activation of Fas and caspase-8 by endogenous FasL is
required for death of motoneurons in the absence of trophic sup-
port. (A) Freshly purified rat motoneurons were induced to die
by culturing them in basal medium only for 24 h, or were kept
alive by addition of an optimal concentration of BDNF (1 ng/ml).
Increasing concentrations of Fas-Fc (0.01–1 mg/ml), which inhib-
its Fas activation by FasL, added to basal medium promoted their
survival (expressed as a percentage of the number in BDNF) in a
dose-dependent manner. Addition of 1 mg/ml of Fas-Fc to moto-
neurons cultured in the presence of BDNF (1 ng/ml) had no ef-
fect on their survival. (B) Immunolabeling of two cultured E12.5
mouse motoneurons using a specific antibody recognizing all
forms of caspase-8. Double-labeling using DAPI (data not
shown) allowed for localization of nuclei (arrows). All motoneu-
rons presented clear granular labeling of the cytoplasm. (C) Af-
ter seeding, rat motoneurons were incubated with increasing
doses of the caspase-8 peptide inhibitor IETD-fmk (0.01–1 mM)
without or with BDNF (1 ng/ml). The number of surviving cells
was measured 24 h later and expressed relative to survival in
BDNF. (D) Western blotting reveals the presence of caspase-8 in
ventral spinal cord from mouse embryos, and in purified mouse
motoneurons. The molecular mass of the major species (43 kD) is
significantly lower than in nonneural cell lines (53–55 kD). 
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in Fig. 5, mouse motoneurons were seeded in a cocktail of
neurotrophic factors, treated with either sFasL or anti-Fas
at 1 DIV, and their survival was counted 4 d later, at 5
DIV (Fig. 7 A). Some motoneurons (
 
z
 
10%) died over the
5-d culture period even in the presence of trophic factors,
and so values were expressed as a percentage of the value
at 5 DIV with trophic factors alone. In these conditions,
Fas activation led to loss of 50% of motoneurons. To rule
out the possibility that incomplete motoneuron loss re-
flected instability of reagents in the culture dish, we then
added Fas activators at both 1 and 3 DIV, and counted
survival at 5 DIV (Fig. 7 B). No further motoneuron loss
was observed, demonstrating that some motoneurons are
truly resistant to Fas activation. We then asked whether
this resistance might be regulated in vitro, by first cultur-
ing motoneurons for 3 DIV in the presence of trophic fac-
tors, then adding Fas activators, and counting survival at 5
DIV. Surprisingly, no motoneuron death at all was trig-
gered in these conditions (Fig. 7 C).
We asked whether all motoneurons might at some stage
be susceptible to Fas activation. Because it was not techni-
cally possible to purify motoneurons from younger em-
bryos, we added sFasL to E14 rat motoneurons at 0 h of
culture. As at 24 h, it was not possible to trigger the death
of more than half of them (data not shown). By extension,
it seems likely that half the motoneurons in situ are al-
ready resistant to Fas activation as cell death begins. To
exclude the possibility that the resistant neurons were in-
trinsically incapable of responding to Fas activation, we
performed the experiment in the presence of cyclohexi-
mide (10 mM). As with many other cell types, this in-
creased the number of motoneurons induced to die by Fas
activators to 80% (two independent experiments; data not
shown).
Regulation of FasL and c-Flip Expression by 
Neurotrophic Factors
Our results suggested: (a) that in the absence of trophic
support, Fas becomes sufficiently activated by FasL to in-
duce motoneuron cell death (Fig. 4); and (b) that in the
presence of trophic factors, motoneurons become resistant
to even exogenous activation of Fas (Fig. 7). We used
semiquantitative RT-PCR to follow the regulation of the
expression of critical molecules in cultured motoneurons.
Purified motoneurons were cultured in the absence and
presence of neurotrophic factors. Cells were harvested af-
ter 1 and 3 DIV and levels of indicated mRNAs were de-
termined by semiquantitative RT-PCR.
First we asked whether trophic deprivation led to upreg-
ulation of components of the Fas system. Levels of Fas,
normalized to actin, were relatively unaffected by the pres-
ence or absence of trophic factors (Fig. 8 B). In contrast,
whereas levels of FasL steadily decreased in motoneurons
cultured with trophic factors, they were strongly upregu-
lated in trophically deprived motoneurons (Fig. 8 A).
Thus, regulation of levels of FasL may underlie the depen-
dence of motoneurons on external trophic support.
Next, we searched for molecular correlates for the state
in which motoneuron death can no longer be triggered by
exogenous Fas activators. As stated above, after a 3-d ex-
posure to BDNF, motoneurons still expressed Fas mRNA
(Fig. 8 B). We confirmed this by demonstrating immu-
noreactivity for Fas at their surface (Fig. 8 D), and further
showed that caspase-8 immunoreactivity was also still
present in treated motoneurons (Fig. 8 E).
Surprisingly, therefore, all major components of the Fas
pathway for cell death were still present in Fas-resistant
motoneurons. This suggested that trophic factor–treated
motoneurons became resistant at a level downstream from
Figure 5. Activation of Fas
triggers PCD of motoneurons
even in the presence of opti-
mal trophic support. Differ-
ent agents known to activate
Fas receptor by clustering
were tested for their ability
to trigger motoneuron cell
death. (A) Purified E12.5
mouse motoneurons were cul-
tured in the presence of
BDNF (1 ng/ml), CT-1 (10 ng/
ml), and GDNF (0.1 ng/ml)
(1NTFs) for 1 d. Subse-
quently, the indicated con-
centrations of anti-Fas anti-
body were added in the
continued presence of NTFs,
and motoneuron survival was counted 2 d later, at 3 DIV. Counts were expressed relative to the value for NTFs at 3 DIV. Fas antibody
induced a dose-dependent loss of 45% of the motoneurons. (B) An analogous experiment using purified motoneurons from E14 rat,
cultured in the continued presence of BDNF (1 ng/ml). After 1 DIV, tagged soluble FasL was added at the indicated concentrations in
the presence of 1 mg/ml of enhancer antibody, which had no effect when tested alone. Survival was counted 2 d later. (C) Comparison of
the fractions of E14 rat motoneurons lost after 2 d of incubation with 10 ng/ml sFasL, in the presence of indicated neurotrophic factors
used at the same concentrations as for mouse motoneurons in A. The number of motoneurons lost was expressed as a percentage of the
total number of motoneurons present in the same conditions but without sFasL. All histograms are representative of at least three inde-
pendent experiments. Error bars represent the mean 6 range of duplicate wells.Raoul et al. Fas Triggers Motoneuron Programmed Cell Death 1057
Fas. Normally, Fas activates caspase-8 through the binding
of the adaptor molecule FADD to the cytoplasmic domain
of Fas. FADD can then recruit procaspase-8 and lead it to
self-activate. FLIP is an endogenous cytoplasmic decoy
that can competitively inhibit the binding of procaspase-8
to FADD, and thereby prevent caspase-8 activation (Fig. 8
E). Using semiquantitative RT-PCR, we showed that
Flip mRNA was strongly upregulated after 3 DIV with
neurotrophic support (Fig. 8 B). Scanning of the gels
showed that the intensity of the Flip band was 6.8-fold
greater at 3 DIV with NTFs than at 1 DIV with NTFs,
when both were expressed relative to the intensity of the
band for actin. To confirm that the change in mRNA levels
was reflected in an increase of FLIP protein, we per-
formed Western blots on cultures of motoneurons in the
same conditions using a specific antibody to mouse FLIP
(Fig. 8 C). As reported in other cell types (Irmler et al.,
1997; Srinivasula et al., 1997), two major molecular species
were labeled by this antibody in motoneuron extracts, with
apparent molecular masses of 52 and 55 kD. Levels of
both were markedly increased at 3 DIV with NTFs. Scan-
ning of the blots showed that there was a mean 6.3-fold in-
crease relative to neurofilament over the 2-d period in cul-
ture. Thus, motoneurons that survive in the presence of
neurotrophic factors not only downregulate the death-
inducer FasL but also upregulate the death inhibitor FLIP.
Discussion
PCD of motoneurons during development of the spinal
cord has long been a classical paradigm, and its study was
at the origin of the discovery of neurotrophic factors (Op-
penheim, 1991; Pettmann and Henderson, 1998). How-
ever, we still know very little about exactly what drives the
death of embryonic motoneurons. We have shown here
that the death receptor Fas and its ligand FasL, which are
coexpressed by motoneurons as they enter the phase of
naturally occurring cell death, may potentially play an im-
portant role. Activation of Fas in cultured embryonic mo-
toneurons is both necessary for PCD in the absence of
neurotrophic factors, and sufficient to trigger death of a
significant proportion of motoneurons in their presence.
Levels of endogenous Fas activators and inhibitors are
regulated by neurotrophic factors, suggesting that the Fas–
FasL system may be a central pathway through which mo-
toneuron numbers are controlled. Further experiments
will be required to determine the role of Fas in naturally
occurring and/or pathological motoneuron cell death in
vivo.
The presence of Fas on developing motoneurons (and
perhaps other spinal neurons) was unexpected, although
Fas expression has recently been reported in both normal
and lesioned adult central nervous system (D’Souza et al.,
Figure 6. Motoneuron cell
death triggered by Fas activa-
tion in the presence of
trophic factors involves
caspases-3 and -8. (A) Acti-
vation of caspase-3 in cul-
tured mouse motoneurons
treated with anti-Fas was vi-
sualized using the CM1 anti-
body, which specifically rec-
ognizes the activated form of
caspase-3. The motoneuron
illustrated was undergoing
apoptosis, as visualized by the fragmented chromatin of the nucleus stained
with DAPI (inset). Note the intense perinuclear staining for activated
caspase-3. (B) Increase in the fraction of CM1-positive mouse motoneu-
rons 30 h after treatment with anti-Fas antibodies in the presence of neu-
rotrophic factors. After immunostaining, CM1-positive motoneurons were
counted along two diameters of 14-mm coverslips (z100 motoneurons
counted for each). All CM1-positive cells showed pyknotic nuclei by DAPI
staining. Values are means 6 SEM of five coverslips, and are typical of two
independent experiments (asterisks indicate P 5 0.001 by t test). Total sur-
vival was not significantly different in the two conditions (P . 0.5; data not
shown). (C) Death of E14 rat motoneurons triggered by sFasL (10 ng/ml) in
the presence of BDNF (1 ng/ml) is inhibited in a dose-dependent fashion by
the caspase-3 peptide inhibitor DEVD-fmk. (D) Death of mouse motoneu-
rons triggered by sFasL (10 ng/ml) and enhancer (1 mg/ml), or anti-Fas anti-
bodies (10 ng/ml), is blocked by DEVD-fmk (10 mM). Survival is expressed as
the percentage of the number of motoneurons surviving in the presence of
BDNF alone. (E) Death of rat motoneurons triggered by sFasL (10 ng/ml, in
the presence of enhancer) is inhibited by the caspase-8 inhibitor IETD-fmk (1
mM). C, D, and E show combined mean values (6 S.D.) from duplicate wells
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1996; Becher et al., 1998a,b; Park et al., 1998; Sakurai et al.,
1998), and a recent paper reported Fas in cerebral cortex
at earlier stages (Cheema et al., 1999). Therefore, we
substantiated this observation by the use of different
techniques (RT-PCR, Western blotting, and immunocy-
tochemistry using several independent antibodies) wher-
ever possible in two different species (mouse and rat). Our
results unequivocally demonstrate the presence of both
Fas and FasL in ventral spinal cord, and freshly purified
motoneurons at the stage at which motoneuron PCD is
about to begin. It will be of interest to determine the pat-
tern of expression of Fas in vivo on a cell-by-cell basis. Our
preliminary data using in situ hybridization and immuno-
histochemistry on rodent spinal cord were not included
here, since Fas and FasL signals are too close to the
threshold of detection. This may also explain apparent dis-
crepancies between our findings and those of French et al.
(1996), who, although they described the presence of FasL
in embryonic spinal cord, reported Fas to be absent from
the embryonic nervous system.
To better understand the potential roles of Fas and
FasL, we studied two potential modes of Fas activation in
vitro: endogenous and exogenous. Motoneurons coexpress
FasL and Fas, and both Fas-Fc and IETD-fmk can prevent
their spontaneous PCD in the absence of trophic factors,
demonstrating that the binding of endogenous FasL to Fas
is a motor for PCD in these conditions. The fact that these
results were obtained in low-density cultures suggests that
this was probably an autocrine effect, as already demon-
strated for T lymphocytes (Brunner et al., 1995; Dhein
et al., 1995). Similar events may occur in cerebellar gran-
ule neurons and PC12 cells which, like motoneurons, up-
regulate FasL in the absence of trophic support (Le-
Niculescu et al., 1999). Our results raise the possibility that
some motoneurons die in vivo by a cell-autonomous Fas-
related mechanism.
Activation of Fas by trophic deprivation is by definition
blocked by neurotrophic factors. In contrast, exogenous
Fas activation inhibited the survival-promoting effects of
all trophic factors we tested. The loss of motoneurons ob-
served in these conditions was very similar in both extent
(50%) and time-course (3–4 d) to motoneuron PCD in the
embryo, although we cannot be sure that the 50% of mo-
toneurons that die in these conditions are the same as the
50% that die from trophic deprivation. This raises the pos-
sibility that some motoneurons in vivo may die not be-
cause they have insufficient trophic support, but because
they have been induced to do so by FasL presented in a
paracrine fashion by nearby cells. Both the autocrine and
paracrine hypotheses will need to be tested during devel-
opment in vivo. Mice bearing either hypomorphic or null
mutations for Fas, or a point mutation in FasL are known
(Watanabe-Fukunaga et al., 1992; Takahashi et al., 1994;
Adachi et al., 1995). We have obtained these mice and are
currently analyzing the detailed pattern of motoneuron
PCD and lesion-induced cell death in the absence of nor-
mal Fas signaling.
It is not certain that Fas plays the same role in all moto-
neurons. It is striking that Fas-Fc and IETD-fmk both pro-
tected at most 75% of the motoneurons that would nor-
mally have died as a result of trophic deprivation. It is
possible that higher concentrations of these reagents were
simply toxic, but this suggests that other Fas-independent
pathways may also be involved in triggering death of some
motoneurons. Another suggestion of heterogeneity comes
from the observation that 50% of motoneurons were resis-
tant to Fas activators in all experimental conditions, even
when treated immediately after purification. Strikingly,
the resistance to Fas activation becomes complete after in-
cubation for 3 d with trophic factors, and this is correlated
with the upregulation of FLIP, an endogenous inhibitor of
caspase-8 activation (Irmler et al., 1997; Tschopp et al.,
1998; Scaffidi et al., 1999). Upregulation of FLIP over time
in culture may reflect either general maturation or a spe-
cific effect of neurotrophic factors. It is not currently possi-
ble to purify rodent motoneurons at different develop-
mental stages, but it will be interesting in the future to
keep motoneurons alive by mechanisms apparently dis-
tinct from the mode of action of trophic factors, e.g., in
high cAMP concentrations (Hanson et al., 1998; Meyer-
Franke et al., 1998), and then test their resistance to Fas
activation at different stages.
Which are the caspases that act downstream of the Fas–
FasL system in inducing motoneuron death? Our results
implicate both caspase-3 and caspase-8. The evidence for
activation of the downstream protease caspase-3 comes
both from inhibitor studies and from immunolabeling us-
ing the CM1 antibody; our results are consistent with the
implication of caspase-3 in many apoptotic phenomena in
neurons (Kuida et al., 1996; Li et al., 1998). In other dying
neurons, activation of the caspase-3 zymogen has gener-
ally been considered to occur through the actions of
caspase-9, and null mutants for this gene indeed show re-
duced neuronal death (Hakem et al., 1998; Kuida et al.,
1998). Our results using the IETD peptide, which inhibits
caspase-8 much more strongly than caspase-3 (Garcia-
Calvo et al., 1998), suggest that Fas acts through caspase-8
in this system as in others (Nagata, 1996). Our conclusions
Figure 7. Resistance of motoneurons to the cell-killing effects of
Fas activation is tightly regulated. Mouse motoneurons were cul-
tured in the continued presence of BDNF, CNTF, and GDNF
(NTFs) and then treated with the Fas activators sFasL (50 ng/ml)
or anti-Fas antibodies (50 ng/ml). Motoneuron survival in all ex-
periments was counted at 5 DIV, and expressed relative to the
value in NTFs alone at that time. (A) Fas activators were added
at 1 DIV only. (B) Fas activators were added at 1 and 3 DIV; no
further motoneuron death was observed. (C) Fas activators were
added at 3 DIV: all motoneurons became resistant to Fas activa-
tion. Histograms are representative of similar results obtained in
three independent experiments. Error bars represent the mean 6
range of duplicate values.Raoul et al. Fas Triggers Motoneuron Programmed Cell Death 1059
are not in agreement with those of a previous report (Li
et al., 1998), whose authors found that caspase-8–like ac-
tivity is present in chick motoneurons but is not upregu-
lated after removal of trophic support, and that motoneu-
rons were not saved by IETD-CHO. This may reflect a
species difference and/or the different form of the peptide
inhibitor used. However, it is clear that our results and
those of Li et al. (1998) need to be substantiated by meth-
ods other than those based on active-site peptides, and we
are currently developing other methods to study activation
of procaspase-8 in the low numbers of motoneurons avail-
able.
Understanding the intracellular mechanisms that regu-
late sensitivity or resistance to the effects of Fas will be
one of the keys to evaluating the role of Fas during normal
motoneuron development, and in pathological systems.
Fig. 8 E presents a possible synthesis of our current knowl-
edge. Fas activation may occur by either endogenous or
exogenous mechanisms. The fact that exogenous (but not
endogenous) activation triggers PCD even in the presence
of neurotrophic factors may simply reflect more intense
activation of caspase-8. This could mean that the signaling
through the Bcl-2 family in the mitochondrion triggered
by NTFs is not sufficient to prevent subsequent release of
cytochrome c and activation of caspase-3 in these condi-
tions (Pettmann and Henderson, 1998). However, in the
medium term (1–3 d), neurotrophic factors can prevent
PCD induced by either endogenous or exogenous Fas acti-
vation. This seems to involve transcriptional events such as
downregulation of FasL or upregulation of FLIP. Unravel-
ing the interplay between these pathways will be impor-
tant for understanding the control of motoneuron survival.
The Fas-dependent mechanism of PCD we have de-
scribed for motoneurons may well be relevant to the study
of other developing neuronal populations, most of which
undergo a quantitatively significant phase of naturally oc-
curring cell death. If our data on spinal motoneurons can
be extrapolated, it may be that sensitivity to Fas activation
will not be apparent at all stages. For instance, in para-
digms involving culture of neurons with neurotrophic fac-
tors for a certain period before withdrawal (Deshmukh
and Johnson, 1997), the neurons under study may become
Figure 8. Regulation of FasL
and FLIP by neurotrophic
factors. (A and B) Levels of
molecules involved in Fas sig-
naling were followed using
semiquantitative RT-PCR on
motoneurons cultured for 1
and 3 DIV in the presence or
absence of neurotrophic fac-
tors. (A) FasL mRNA is up-
regulated in motoneurons
cultured in the absence of
trophic factors. (B) Regula-
tion of fas and FLIP mRNAs.
mRNA samples were incu-
bated with (1) or without
(2) reverse transcriptase. Fas
was expressed at relatively
constant levels when normal-
ized to actin, whereas FLIP
was strongly upregulated in
motoneurons cultured for 3
DIV in the presence of NTFs.
(C) Strong upregulation of
FLIP protein in the presence
of neurotrophic factors.
Western blots are shown of
extracts of purified motoneu-
rons cultured for 1 and 3 DIV
in the presence of NTFs; two
major forms of FLIP at 55
and 52 kD are observed. The
loading control was neurofila-
ment-68. (D) Immunolabel-
ing of Fas-resistant mouse
motoneurons cultured for 3 d
in the presence of NTFs, us-
ing the blot-purified poly-
clonal antibodies against Fas characterized in Fig. 2. Fas continues to be expressed at the cell membrane. (E) Motoneurons treated for
3 d with NTFs also continue to express caspase-8. (F) Summary diagram showing the potential involvement of the Fas system in PCD of
motoneurons. The main experimental strategies adopted in our study of the role of Fas are depicted. In addition, we have indicated the
three levels at which neurotrophic factors may potentially act to block Fas-related motoneuron death.The Journal of Cell Biology, Volume 147, 1999 1060
resistant to Fas activation before the stage at which their
cell death is normally studied. An interesting possibility is
that, just as different cell populations seem to depend for
cell death on different members of the Bcl-2 family (Deck-
werth et al., 1996) or on different caspases (Troy et al.,
1996), different members of the tumor necrosis factor
(TNF) receptor family such as p75 and Fas may be in-
volved in the programmed elimination of different groups
of neurons.
It will be important to determine whether triggering of
motoneuron death by Fas might underlie the specific loss
of motoneurons that is observed in some circumstances at
later stages of development or in the adult. These include
experimental or traumatic lesions, and the neurodegenera-
tive diseases that affect motoneurons, such as the pmn or
wobbler mutations in mice, and spinal muscular atrophies
(SMA) or amyotrophic lateral sclerosis (ALS) in humans
(Henderson, 1995). If Fas expression is observed in these
patients, the pathways downstream of Fas may provide a
novel and specific site for therapeutic intervention in these
still incurable diseases.
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